InvestorsHub Logo
Followers 59
Posts 3991
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Sunday, 07/14/2024 3:27:26 PM

Sunday, July 14, 2024 3:27:26 PM

Post# of 427087
$AMRN CHINA: Fertile Territory for VAZKEPA®! The number of new cases of CVD (the Incidence) in China is on the rise and dwarfs those in the USA. This data from the Global Burden of Disease Database shows the steady rise (2-3% annually) in China vs the relative steady cases in the USA.

The enormity of the potential market for VAZKEPA® in China can’t be discounted at any reimbursement price. This is truly a VOLUME Play.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News